Gilead Sciences stock soars after it touts Remdesivir trial results
17.04.2020
An announcement this week by the US pharmaceutical company specializing in virus research and medicine, Gilead Sciences, caused a three percent jump in the S&P 500 index after the market closed, while the company's own shares moved up 15
